There is a new horror story haunting the Hamptons this season: the $15 generic. Indian pharmaceutical firms are flooding the Global South with dirt-cheap semaglutide. They are turning the ultimate status symbol into a common commodity. If everyone can be thin, then being thin no longer has value.

Thankfully, Novo Nordisk has launched 'Wegovy HD' in the United States. This higher-dose injectable is the new velvet rope for your metabolism. It is the medical equivalent of a private island. While the masses scramble for budget generics, the true elite are moving to the premium HD subscription.

Being thin is no longer about discipline. It is about the ability to pay the subscription fee. The 'Metabolic Divide' is the new class boundary. On one side, you have the HOBIT 'living pharmacy' implants that keep the super-rich perfectly balanced. On the other, you have the unwashed masses and their 'trashy' generics.

We must defend these patents at all costs. If weight loss becomes a human right, it loses its aesthetic charm. A zero-percent body fat ratio should remain an exclusive luxury, not a public utility. The elite deserve a body that reflects their bank account, not their proximity to a pharmacy in Mumbai.